Bioquell PLC (LSE:BQE) - Share price - Overview

Stock Report

Bioquell PLC BQE

Last Price
GBX150.85

Day Change
4.85|3.32%

As of 24/03/2017
10:50:12 GMT | GBX
Minimum 15 Minutes Delay.

Last Close146.00p
Day Range146.90 - 150.85
Mkt Cap32.58Mil
52-Wk Range119.50 - 178.00
Yield %0.00
ISINGB0004992003
Volume14,022
P/E27.80
P/S2.39
P/CF12.07

Share Price

Total Returns 23/03/2017

 Chg (%)  
More ...
Bioquell PLC13.18 
FTSE 100 TR GBP1.19
 
Financials
201420152016
More ...
Income Statement
Turnover27.2726.88-
Operating Profit-4.680.55-
Net Profit-3.780.64-
Reported EPS-8.901.50-
Balance Sheet
Current Assets17.9956.55-
Non Current Assets24.1514.31-
Total Assets42.1370.86-
Current Liabilities7.654.59-
Total Liabilities11.085.94-
Total Equity31.0664.92-
Cash Flow
Operating Cash Flow3.885.25-
Net Change in Cash-0.7144.72-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20171.936.8826.7221.230.80--
20182.348.3521.4817.480.813.502.40
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
21/06/2016SaleMr. Christopher Mills200.006,305,00012,610,000.00
21/06/2016SaleMr. Simon Constantine200.00235,000470,000.00
21/06/2016SaleMr. Nick Adams200.00513,6971,027,394.00
21/06/2016SaleMr. Michael Roller200.009,62219,244.00

Company Profile

Bioquell PLC is engaged in the design, manufacture and supply of bio-decontamination and containment equipment, related products and services to the healthcare, life sciences and defence industries.

Sector

Medical Devices

Market Position

1236 of 1853 Companies

Index

FTSE Fledgling

Outlook

(07/03/2017) "...the board remains confident in delivering further growth in revenue and profits"

Next Event 31/03/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)20.2618.3116.14
Div Yld (E)0.001.694.12
PEG (E)0.800.461.08
ROCE0.0028.10-17.01
Op Mrgn0.00-9.34-22.83
EPS Grwth25.3235.7540.53
Dividends
PreviousLatest
More ...
Record Date06/06/1405/06/15
Ex-Div04/06/1404/06/15
Paid02/07/1402/07/15
Amnt3.303.30

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Ian Johnson
Group Finance DirectorMr. Michael Roller
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.